HomeBusiness NewsPfizer to discontinue twice-daily weight loss pill due to high rates of...

Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects

- Advertisement -spot_imgspot_img

Pfizer said it still plans to release phase two trial data on a once-a-day version of its weight loss drug, known as danuglipron, in the first half of 2024…

- Advertisement -spot_imgspot_img
Stay Connected
16,985FansLike
4,568FollowersFollow
Must Read
Related News

LEAVE A REPLY

Please enter your comment!
Please enter your name here